Mark S. Blumenkranz's Net Worth
$12.1 Million
Who is Mark S. Blumenkranz?
Mark S. Blumenkranz has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include IVERIC bio, Inc., 1Life Healthcare Inc, Avalanche Biotechnologies, Inc., Presbia PLC, and Kala Pharmaceuticals, Inc..
SEC CIK
Mark S. Blumenkranz's CIK is 0001614869
Past Insider Trading and Trends
2023 was Mark S. Blumenkranz's most active year for acquiring shares with 10 total transactions. Mark S. Blumenkranz's most active month to acquire stocks was the month of April. 2015 was Mark S. Blumenkranz's most active year for disposing of shares, totalling 26 transactions. Mark S. Blumenkranz's most active month to dispose stocks was the month of April. 2014 saw Mark S. Blumenkranz paying a total of $29,995.00 for 101,682 shares, this is the most they've acquired in one year. In 2015 Mark S. Blumenkranz cashed out on 231,000 shares for a total of $10,418,489.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IVERIC bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -32.09K |
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +83.36% | 14.59K |
—
|
—
| 32.09K |
May 11
| |||
Form 4
| +40.00% | 5K |
—
|
—
| 17.5K |
Jul 15
| |||
Form 4
| +150.00% | 7.5K |
—
|
—
| 12.5K |
May 11 - May 12
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
1Life Healthcare Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.53K |
$18.00 | -$81,612.00 |
0
|
Feb 22
| |||
Form 4
|
∞
| 4.53K |
—
|
—
| 4.53K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avalanche Biotechnologies, Inc. (ADVM) Snapshot price: $2.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.59% | 8.33K |
—
|
—
| 531.32K |
Feb 12
| |||
Form 4
| -0.36% | -1.90K |
$39.97 | -$75,939.20 | 522.99K |
Scheduled
|
Jun 11
| ||
Form 4
| -4.22% | -23.10K |
$35.86 | -$828,276.08 | 524.89K |
Scheduled
|
Jun 9 - Jun 10
| ||
Form 4
| -0.90% | -5.00K |
$40.08 | -$200,414.00 | 547.99K |
Scheduled
|
Jun 5
| ||
Form 4
| -8.67% | -3.00K |
$36.91 | -$110,733.60 | 31.59K |
Scheduled
|
May 19
| ||
Form 4
| -3.91% | -22.50K |
$35.49 | -$798,552.53 | 552.99K |
Scheduled
|
May 15
| ||
Form 4
| -0.12% | -715.00 |
$34.94 | -$24,984.17 | 575.49K |
Scheduled
|
May 13
| ||
Form 4
| -0.31% | -1.78K |
$34.91 | -$62,322.56 | 576.2K |
Scheduled
|
May 11
| ||
Form 4
| -3.34% | -20.00K |
$32.37 | -$647,306.00 | 577.99K |
Scheduled
|
May 1
| ||
Form 4
| +0.34% | 2K |
—
|
—
| 597.99K |
Apr 21
| |||
Form 4
| -4.03% | -25.00K |
$41.59 | -$1,039,753.20 | 595.99K |
Scheduled
|
Apr 16
| ||
Form 4
| -4.10% | -28.00K |
$38.64 | -$1,084,208.53 | 655.58K |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| -13.41% | -100.00K |
$55.46 | -$5,546,000.00 | 645.99K |
Jan 13
| |||
Form 4
| +11.94% | 83.58K |
$0.15 |
—
| 783.58K |
Aug 5
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Presbia PLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 9.27K |
—
|
—
| 9.27K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALA BIO, Inc. (KALA) Snapshot price: $7.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.98% | 1.4K |
—
|
—
| 13.09K |
Jun 11
| |||
Form 4
| +71.75% | 4.88K |
—
|
—
| 11.69K |
Jun 22
| |||
Form 4
| +65.26% | 69.71K |
—
|
—
| 176.54K |
Feb 15 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 5.34M |
—
|
—
| 5.34M |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||